Maat Pharma SA Working Capital to Net Assets Ratio
Maat Pharma SA working capital to net assets ratio. Maat Pharma SA (MAAT) has a Working Capital to Net Assets ratio of 235.4% as of June 2025. Working capital of €19.53 Million (current assets of €35.57 Million minus current liabilities of €16.04 Million) is measured against net assets of €8.29 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Maat Pharma SA's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Maat Pharma SA (2017–2024)
Working capital to net assets ratio of Maat Pharma SA from 2017 to 2024. This chart shows how Maat Pharma SA's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 235.4%, reflecting working capital of €19.53 Million against net assets of €8.29 Million EUR. See Maat Pharma SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Maat Pharma SA Working Capital to Net Assets Ratio by Year (2017–2024)
Maat Pharma SA working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Maat Pharma SA from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Maat Pharma SA balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 126.6% | €13.08 Million | €10.34 Million | €27.64 Million | €14.56 Million | ▲ +26.5 pp |
| 2023 | 100.0% | €20.47 Million | €20.47 Million | €31.99 Million | €11.52 Million | ▼ -22.7 pp |
| 2022 | 122.7% | €32.91 Million | €26.81 Million | €42.12 Million | €9.22 Million | ▲ +15.9 pp |
| 2021 | 106.8% | €42.57 Million | €39.86 Million | €47.27 Million | €4.70 Million | ▼ -14.5 pp |
| 2020 | 121.3% | €19.33 Million | €15.94 Million | €22.19 Million | €2.86 Million | ▲ +216.6 pp |
| 2019 | -95.3% | €4.35 Million | €-4.57 Million | €6.98 Million | €2.63 Million | ▼ -291.3 pp |
| 2018 | 196.0% | €2.49 Million | €1.27 Million | €4.73 Million | €2.24 Million | ▲ +56.7 pp |
| 2017 | 139.3% | €7.34 Million | €5.27 Million | €8.79 Million | €1.45 Million | — |